Evidence map›Paper›PMID 41234843›Full record

ArticleTranslational cancer research2025

Single-cell analysis revealed a diagnostic model of hepatocellular carcinoma based on cancer stem cell-related gene.

Yang Ding, Qi Liang, Songbo Ma, Jia Yang, Zengrui Ma, Zhiqi Yang, Baoding Li

Abstract read
In one paragraph

Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yang Ding *Department of Hepatobiliary Surgery, People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, China.
Qi Liang *Department of Hepatobiliary Surgery, People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, China.
Songbo MaDepartment of Hepatobiliary Surgery, People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, China.
Jia YangDepartment of Hepatobiliary Surgery, People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, China.
Zengrui MaDepartment of Anesthesiology, People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, China.
Zhiqi YangDepartment of Hepatobiliary Surgery, People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, China.
Baoding LiDepartment of Hepatobiliary Surgery, People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cancer stem cells (CSCs) play a pivotal role in hepatocellular carcinoma (HCC) pathogenesis, driving tumor initiation, progression, metastasis, and therapeutic resistance. This study aimed to establish a reliable CSC-based signature for HCC through single-cell analysis. Methods: The study integrates single-cell RNA sequencing (scRNA-seq) data with the Dynamic Data Retrieval Tree (DDRTree) algorithm to identify and characterize CSCs in HCC. A prognostic stemness-associated gene signature was constructed using the Cancer Genome Atlas-Liver hepatocellular carcinoma (TCGA-LIHC) cohort as the training set and validated across two independent HCC datasets (GSE14520-GPL571 and GSE14520-GPL3921). Genes with significant prognostic relevance to CSC biology were prioritized for signature inclusion. The efficacy of model was assessed via survival analysis (Kaplan-Meier) and predictive accuracy evaluation [time-dependent receiver operating characteristic (ROC) curves], demonstrating robust stratification of high- versus low-risk HCC patients and strong prognostic discrimination. Results: A total of 17 CSC-related signatures in HCC were identified by copy number variation (CNV) pattern. Then, we constructed 4-CSCs-related gene predictive model by multivariate Cox regression. The model robustly stratified patients into high- and low-risk cohorts, with high-risk individuals exhibiting markedly reduced overall survival (OS). Kaplan-Meier analysis confirmed significant survival disparity between groups (P<0.001), while time-dependent ROC curves validated the model high predictive accuracy. This prognostic signature may guide the development of personalized therapeutic strategies for HCC. Conclusions: The prognostic model consisted of 4-CSC-related genes had a prognostic predictive value, providing a new perspective for precision immuno-oncology studies.

Indexed as

Cancer stem cells (CSCs)hepatocellular carcinoma (HCC)immuneprognosis

Identifiers

PMID41234843
PMCPMC12605633

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.